Ceruvia Lifesciences Appoints Stephen Hurst and David Steinb

GREENWICH, Conn., Nov. 2, 2022 /PRNewswire/ -- Ceruvia Lifesciences, a leading neurotransformational biopharmaceutical company, is pleased to announce the appointment of Stephen Hurst and David

Related Keywords

United States , America , Ceruvia Lifesciences , Kostenloser Wertpapierhandel , David Steinberg , Stephen Hurst , Carey Turnbull , Prnewswire Ceruvia Lifesciences , School Of Medicine , Nektar Therapeutics Inc , Institutional Investor All America Research Team Most , World Bank , Sequential Inc , Harvard Medical School , Deutsche Bank , Venture For Global Health , Inhale Therapeutic Systems Inc , Yale University School Of Medicine , Inhale Therapeutic Systems , Nektar Therapeutics , Global Health , Mind Medicine , Wall Street , Managing Director , Institutional Investor , America Research Team , Wall Street Journal , Yale University School , Ceruvia , Lifesciences , Ppoints , Stephen , Burst , David , Steinberg , Board , Directors ,